WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flores, C.
Right arrow Articles by Stewart, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flores, C.
Right arrow Articles by Stewart, J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 15, 1998, 18(22):9547-9555

Long-Lasting Induction of Astrocytic Basic Fibroblast Growth Factor by Repeated Injections of Amphetamine: Blockade by Concurrent Treatment with a Glutamate Antagonist

Cecilia Flores, Demetra Rodaros, and Jane Stewart

Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montreal, Quebec, Canada, H3G 1M8

Repeated administration of stimulant drugs leads to lasting changes in their behavioral and neurochemical effects. These changes are initiated by drug actions in the somatodendritic regions of midbrain dopaminergic neurons in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) and continue to develop for a period of time after termination of drug treatment. Here we show that repeated administration of amphetamine (3.0 mg/kg, i.p.; three injections, once every other day) results in sustained increases in basic fibroblast growth factor immunoreactivity (bFGF-IR) in both VTA and SNc, 200-500% over that seen in saline-treated animals. Increases were observed 24 hr, 72 hr, 1 week and 1 month after the last drug injection. Because glutamate participates in the development of sensitization to stimulant drugs, we assessed the effect of the glutamate antagonist, kynurenic acid (KYN), on amphetamine-induced bFGF-IR. Coadministration of KYN prevented the increases in bFGF-IR in both VTA and SNc assessed 1 week after the amphetamine treatment. No changes in bFGF-IR were observed in the nucleus accumbens or dorsal striatum. bFGF-IR was found to be associated with astrocytes and not with dopaminergic neurons. These findings suggest that sustained enhancement of astrocytic bFGF expression in DA somatodendritic regions is a mechanism whereby stimulant drugs exert enduring effects on midbrain DA function. We hypothesize that increased glutamatergic activity elicited by amphetamine and other stimulant drugs places excessive demands on the functioning of DA neurons recruiting regulatory and neuroprotective processes that lead to enduring changes in DA neuron functioning and connectivity.

Key words: bFGF; amphetamine; sensitization; glutamate; dopamine; neurotrophic factors


Copyright © 1998 Society for Neuroscience  0270-6474/98/18229547-09$05.00/0


This article has been cited by other articles:


Home page
StrokeHome page
C. M. Papadopoulos, S.-Y. Tsai, V. Guillen, J. Ortega, G. L. Kartje, and W. A. Wolf
Motor Recovery and Axonal Plasticity With Short-Term Amphetamine After Stroke
Stroke, January 1, 2009; 40(1): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
J. Stewart
Psychological and neural mechanisms of relapse
Phil Trans R Soc B, October 12, 2008; 363(1507): 3147 - 3158.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Kaga, W. J. Shoemaker, M. Furusho, M. Bryant, J. Rosenbluth, S. E. Pfeiffer, L. Oh, M. Rasband, C. Lappe-Siefke, K. Yu, et al.
Mice with Conditional Inactivation of Fibroblast Growth Factor Receptor-2 Signaling in Oligodendrocytes Have Normal Myelin But Display Dramatic Hyperactivity when Combined with Cnp1 Inactivation.
J. Neurosci., November 22, 2006; 26(47): 12339 - 12350.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Kolb, G. Gorny, Y. Li, A.-N. Samaha, and T. E. Robinson
Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens
PNAS, September 2, 2003; 100(18): 10523 - 10528.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. B. NICULESCU III, D. S. SEGAL, R. KUCZENSKI, T. BARRETT, R. L. HAUGER, and J. R. KELSOE
Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach
Physiol Genomics, November 9, 2000; 4(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Flores, N. Salmaso, S. Cain, D. Rodaros, and J. Stewart
Ovariectomy of Adult Rats Leads to Increased Expression of Astrocytic Basic Fibroblast Growth Factor in the Ventral Tegmental Area and in Dopaminergic Projection Regions of the Entorhinal and Prefrontal Cortex
J. Neurosci., October 1, 1999; 19(19): 8665 - 8673.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Flores, A.-N. Samaha, and J. Stewart
Requirement of Endogenous Basic Fibroblast Growth Factor for Sensitization to Amphetamine
J. Neurosci., January 15, 2000; 20(2): RC55 - RC55.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-